101/238US=9 / Urologia
Harzstark AL, Fong L. CTLA-4 blockade for prostate cancer treatment. In: Figg WD, Chau CH, Small EJ. Drug management of prostate cancer. New York: Springer - Verlag, 2010. p. 243-8. ISBN 978-1-60327-831-7.

CTLA-4; IMUNOTERAPIA; CTLA-4 BLOQUEIO; IPILIMUMAB


102/238US=23-E / Câncer
Tomita Y, Maruyama R, Itoi T, Bilim V. Metastatic renal cell carcinoma: use of Bcl-2 and Fas to predict responses to immunotherapy. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 137-45. ISBN 978-90-481-2917-1.

CARCINOMA; METASTATICO DE CELULAS RENAIS; BCL-2 E FAS; IMUNOTERAPIA


103/238US=23-E / Câncer
Chatterjee M, Manivannan R, Pande A, Chakraborty T. Immunotherapeutic strategies, radiotherapy, and targeted radionuclide therapy approaches for the treatment of multiple myeloma. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: ovarian cancer, renal cancer, urogenitary cancer, urinary bladder cancer, cervical uterine cancer, skin cancer, leukemia, multiple myeloma and sarcoma. New York: Springer, 2010. p. 361-82. ISBN 978-90-481-2917-1.

ESTRATEGIAS DE IMUNOTERAPIA; RADIOTERAPIA; TERAPIA; RADIONUCLIDEOS PARA O TRATAMENTO DO MIELOMA MULTIPLO


104/238US=1-A / Farmacologia
Krensky AM, Vicenti F, Bennett WM. Imunossupressores, tolerógenos e imunoestimulantes. In: Brunton LL, Lazo JS, Parker KL. Goodman & Gilman: as bases farmacológicas da terapêutica. 11ª ed. Porto Alegre: AMGH, 2010. p. 1265-89. ISBN 85-6330801-6.

SISTEMA IMUNOLOGICO; AGENTES IMUNOSSUPRESSORES; ESTEROIDES ADRENOCORTICAIS; INIBIDORES DA CALCINEURINA; AGENTES ANTIPROLIFERATIVOS; AGENTES ANTIMETABOLICOS; SIROLIMUS; EVEROLIMUS; AZATIOPRINA; MICOFENOLATO-MOFETILA; FTY720; ANTICORPOS POLICLONAIS; ANTICORPOS MONOCLONAIS; IMUNOESTIMULACAO; IMUNOTERAPIA PARA ESCLEROSE MULTIPLA


105/238US=26-A / Radioterapia
Ang KK, O'Reilly MS, Meyn RE Jr, Milas L. Principles of combining radiation therapy and molecular therapeutics. In: Cox JD, Ang KK. Radiation oncology: rationale, technique, results. 9ª ed. Philadelphia: Elsevier Mosby, 2010. p. 118-37. ISBN 978-0-323-04971-9.

RADIOTERAPIA; TRATAMENTO DO CANCER; TERAPIA MOLECULAR; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; ANGIOGENESE; AGENTES ANTIANGIOGENICOS; CICLOOXIGENASE; VIA DE SINALIZACAO RAS; TERAPIA GENICA; IMUNOTERAPIA


106/238US=2 / Ginecologia
Muggia F, Gold LI, Curtin J. Future directions: new targets. In: Muggia F, Oliva E. Uterine cancer: screening, diagnosis, and treatment. New York: Humana Press, 2009. p. 267-83. ISBN 978-1-588-29-736-5.

ALVOS MOLECULARES; IMUNOTERAPIA; PTEN; MTOR; HORMONIO; RECEPTORES


107/238US=4 / Ginecologia
Sabbatini PJ, Chang DZ, Divgi CR, Livingston PO, Houghton AN. Immunotherapy of gynecologic malignancies. In: Barakat RR, Markman M, Randall ME. Principles and practice of gynecologic oncology. 5ªed. Philadelphia: Lippincott Williams & Wilkins, 2009. p. 113-43. ISBN 978-0-7817-7845-9.

IMUNOTERAPIA DE NEOPLASIAS MALIGNAS GINECOLOGICAS; CANCER DE IMUNOLOGIA; IMUNOMODULACAO DE CITOCINAS E TERAPIA; MEDIADA POR ANTICORPOS TERAPIA DE CANCER; ANTICORPOS MONOCLONAIS; TERAPIA CELULAR ADOTIVA; VACINAS CONTRA O CANCER; LINFOCITOS T RESPOSTAS


108/238US=8 / Cab/Pescoço
Chapoval AI, Schulze DH, Strome SE. Immunotherapy for head and neck cancer. In: Snow JB Jr, Wackym PA. Ballenger's otorhinolaryngology head and neck surgery. 17ª ed. Lewiston: BC Decker, 2009. p. 1055-61. ISBN 1-55009-337-7.

IMUNOTERAPIA PARA CANCER DE CABECA E PESCOCO; IMUNOTERAPIA DE CANCER; DESAFIOS PARA IMUNOTERAPIA DE CANCER; CANCER DE CABECA E PESCOCO; IMUNOTERAPIA PASSIVA DE CANCER


109/238US=15 / Biol/Mol
Platt VM, Szoka FC Jr. Exploiting the hyaluronan - CD44 interaction for cancer therapy. In: Stern R. Hyaluronan in cancer biology. Amsterdam: Elsevier, 2009. p. 379-403. ISBN 978-0-12-374178-3.

CANCER; ACIDO HIALURONICO; CD44; INTERACAO ACIDO HIALURONICO CD44; QUIMIOTERAPICOS; IMUNOTERAPIA


110/238US=11 / Fisiologia
Vickers PS. Cancer. In: Nair M, Peate I. Fundamentals of applied pathophysiology: an essential guide for nursing students. Oxford: John Wiley & Sons, 2009. p. 34-60. ISBN 978-0-470-51795-6.

CANCER; TUMOR; ONCOGENE; QUIMIOTERAPIA; CARCINOGENES; RADIOTERAPIA; IMUNOTERAPIA; CARCINOMA; NEOPLASMA; CITOTOXICIDADE; CANCER. BIOLOGIA; CANCER. CAUSAS; CANCER. ESTADIAMENTO; CANCER. SINTOMAS; CANCER. TRATAMENTO; CANCER. PREVENCAO; LEUCEMIA LINFOBLASTICA AGUDA; CANCER DE PULMAO; CANCER DE MAMA


111/238US=22 / Urologia
Inman BA, Frigola X, Dong H, Yang JC, Kwon ED. Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 367-403. ISBN 978-1-58829-737-2.

COESTIMULACAO; INIBICAO; IMUNOLOGIA DE TUMORES; IMMUNOEDITING; IMUNOTERAPIA; LINFOCITOS T; CARCINOMA DE CELULAS RENAIS


112/238US=24 / Biol/Mol
Arruda LK, Trombone APF, Genov IR. Imunoterapia alérgeno-específica. In: Voltarelli JC, editor. Imunologia clínica na prática médica. São Paulo: Atheneu, 2009. p. 1063-70. ISBN 85-7379920-0.

IMUNOTERAPIA ALERGENO-ESPECIFICA; IMUNOTERAPIA; IMUNOTERAPIA SUBLINGUAL; IMUNOTERAPIA PARA ASMA


113/238US=27 / Fisioterapia
Koehne G. Principles of immunotherapy. In: Stubblefield MD, O'Dell MW. Cancer rehabilitation: principles and practice. New York: DemosMedical, 2009. p. 53-71. ISBN 978-19-338643-34.

PRINCIPIOS DA IMUNOTERAPIA; PRINCIPIOS DA TERAPIA IMUNE CELULAR; PRINCIPIOS DA TERAPIA IMUNITARIA HUMORAL; PRINCIPIOS DE VACINAS CONTRA O CANCRO


114/238US=27 / Fisioterapia
Wolchok JD, Saenger Y. Evaluation and treatment of melanoma. In: Stubblefield MD, O'Dell MW. Cancer rehabilitation: principles and practice. New York: DemosMedical, 2009. p. 225-33. ISBN 978-19-338643-34.

AVALIACAO E TRATAMENTO DE MELANOMA; BIOLOGIA DOS MELANOCITOS; IMUNOTERAPIA EXPERIMENTAL EM MELANOMA; LESOES GENETICAS EM MELANOMA


115/238US=48 / Biol/Mol
Chatterjee M, Wojciechowski J, Tainsky MA. Discovery and antibody biomarkers using protein microarrays of tumor antigens cloned in high throughput. In: Tainsky MA. Tumor biomarker discovery: methods and protocols. New Jersey: Humana Press, 2009. p. 21-38. (Methods in Molecular Biology 520) ISBN 978-1-60327-810-2.

RESPOSTA IMUNE; BIOMARCADORES TUMORAIS; AUTO-ANTICORPOS; EPITOPOS; DETERMINANTE ANTIGENICO; MICROARRAYS DA PROTEINA; IMUNOTERAPIA


116/238US=50 / Câncer
Oble DA, Hodi S, Lauwers GY, Dranoff G, Mihm Jr MC. Treg' chemokines, and other small molecules: role in metastasis and its prevention: experiences in melanoma immunobiology. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 263-79. ISBN 978-1-60327-086-1.

TIL; MELANOMA; IMUNOTERAPIA; CTLA-4; QUIMIOCINA; IMUNOBIOLOGIA; METASTASE; IMUNORREGULADORA; TREG'; ANTICORPO MONOCLONAL; ADJUVANTE


117/238US=50 / Câncer
Lee WT, Shu S. Role of lymph nodes in immunotherapy of malignant tumors. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 391-400. ISBN 978-1-60327-086-1.

GANGLIOS LINFATICOS NA IMUNOTERAPIA DE TUMORES MALIGNOS; IMUNOTERAPIA; LINFONODO; MALIGNIDADE; HIBRIDOS DE FUSAO


118/238US=50 / Câncer
Wei S, Shreiner AB, Chang AE. Vaccine-primed lymph node cells in the adoptive immune suppression induced by established cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 425-32. ISBN 978-1-60327-086-1.

CELULAS T; IMUNOSSUPRESSAO; IMUNOTERAPIA ADOPTIVA; VACINAS; LINFONODOS


119/238US=50 / Câncer
Ryan CJ. Development in the management of genitourinary malignancies: prostate cancer and renal cell carcinoma. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 533-44. ISBN 978-1-60327-086-1.

DOENCAS MALIGNAS DO APARELHO GENITURINARIO; CANCER DE PROSTATA; CARCINOMA DE CELULAS RENAIS; CASTRACAO-RESISTENTE O CANCER DE PROSTATA; ANDROGENIOS ADRENAIS; IMUNOTERAPIA; FASE II; ABIRATERONA; ATRASENTAN; BEVACIZUMAB; CALCITRIOL; QUIMIOTERAPIA; GVAX; IPILIMUMAB; IXABEPILONA; SATRAPLATIN; SIPULEUCEL-T; VEGF; SUNITINIB; SORAFENIB


120/238US=50 / Câncer
Chmielowski B, Ribas A. Targeting immunological synapse: new horizons in immunotherapy for cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 575-90. ISBN 978-1-60327-086-1.

SEGMENTACAO SINAPSE IMUNOLOGICA; IMUNOTERAPIA PARA O CANCER; IMUNOTERAPIA; SINAPSE IMUNOLOGICA; CTLA-4; AUTO-IMUNIDADE; MELANOMA; CANCER


Primeira | Anterior | Próxima | Última